ClinicalTrials.gg
Not yet recruitingNCT07606209PRIMEUpdated Oct 9, 2026

Emergency and Urgent Care Indicators in Piedmont

An observational study in Emergency Departments, sponsored by Mario Negri Institute for Pharmacological Research. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Mario Negri Institute for Pharmacological Research · Observational

Updated Oct 9, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
650,000
Ages
18 Years and older
Sex
All
01

Study summary

The Emergency Department represents the main entry point to the hospital and a key setting for the management of urgent healthcare needs in the population. To date, the assessment of care quality has mainly focused on organizational aspects, with limited structured tools to systematically measure clinical and care processes.

Overcrowding and limited resources make dedicated data collection unsustainable; therefore, it is necessary to rely on data already available from routine healthcare information systems. In this context, the study aims to assess the feasibility of using these data to construct quality indicators, as well as to evaluate their availability and reliability across participating centers.

The study will also analyze variability in indicators among participating Emergency Departments, with the goal of identifying differences in care processes and potential areas for improvement.

Read the detailed description

The Emergency Department (ED) is the primary gateway to the hospital system, yet its quality has traditionally been measured only by organizational efficiency rather than clinical care.

This study introduces a program to monitor the quality of assistance through standardized indicators, shifting the focus toward clinical and care appropriateness. Because Italian EDs face chronic overcrowding and resource shortages, the study is designed to be sustainable by using data already collected during routine clinical practice (current data flows) instead of requiring new, active data collection by staff.

The main goal of this pilot study is to build a reliable monitoring system. First, it verifies if the necessary data are actually available and accurate within existing hospital databases. Second, it measures the quality of care provided by participating centers to identify significant variations in clinical processes.

Finally, it aims to provide centers with detailed reports to help them interpret these findings and identify areas for improvement.

This is a multicenter, retrospective, observational cohort study involving at least 10 EDs. The study analyzes all patient visits over a three-year period, from January 2023 to December 2025, to account for seasonal trends and the evolution of care over time.

A total of 13 indicators are evaluated:

  • Mandatory Indicators: These focus on critical issues like "boarding" (the time spent waiting for a hospital bed), overall overcrowding, wait times for clinical visits, and the management of time-dependent conditions like sepsis.
  • Optional Indicators: These explore aspects such as the re-evaluation of patients in the waiting room, the use of "fast-track" assignments, and safety metrics like the frequency of falls among elderly patients.

Data are extracted from hospital information systems and transferred via secure protocols for analysis. All information is pseudonymized at the source to protect patient privacy. The analysis assesses the reliability of the data and uses statistical tests to compare performance between different centers and over time. As a pilot project, this study serves to identify which indicators are robust enough to be included in a permanent, large-scale quality improvement framework.

02

Conditions studied

  • Emergency Departments

Browse trials for

03

In context

Lead sponsor

Mario Negri Institute for Pharmacological Research is the lead sponsor of 160 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients aged 18 years and older presenting to participating Emergency Departments during the period from 1 January 2023 to 31 December 2025.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (age >18 years) who presented to the participating Emergency Departments between 1/1/2023 and 31/12/2025.

Exclusion criteria

Exclusion Criteria:

  • All patients under 18 years.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
650,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Eligible population

    Adult patients (age \>18 years) who presented to the participating Emergency Departments between 1/1/2023 and 31/12/2025.

06

What researchers measure

Primary outcomes

  1. To verify the availability and reliability of data for the construction of indicators on the quality of care in Emergency Departments (EDs) in the hospital databases of the participating centers.

    Data availability for calculating quality-of-care indicators in emergency departments will be assessed without statistical analyses. Data reliability will be evaluated by a multidisciplinary working group (statisticians, emergency physicians, nurses, and hospital information/management staff), considering clinical relevance, missing or incomplete data, and internal consistency. This approach will document potential limitations in data quality across participating hospital databases.

    Time frame: July 2026 - November 2026

  2. Rate of adherence to quality-of-care indicators per participating emergency department

    Quality-of-care indicators will be calculated and, for each of them, 95% confidence intervals will be reported to quantify estimation uncertainty. Differences across participating emergency departments will be assessed using descriptive statistics (means, standard deviations, medians, interquartile ranges, boxplots, and histograms) and inferential tests appropriate to the indicator type: ANOVA and Kruskal-Wallis tests for quantitative indicators, and proportion difference tests for indicators expressed as percentages.

    Time frame: April 2027 - July 2027

  3. Change in quality-of-care indicator rates over the three-year study period

    Temporal trends in quality-of-care indicators will be analyzed across the three-year data collection period (2023-2025) to quantify variations observed over time within and across participating emergency departments.

    Time frame: December 2026 - March 2027

  4. Proportion of patients managed in accordance with predefined quality-of-care indicators per participating emergency department

    Quality-of-care indicators will be calculated according to predefined criteria, with 95% confidence intervals to quantify estimation uncertainty. Variability across participating emergency departments will be assessed using descriptive methods (means, standard deviations, medians, interquartile ranges, boxplots, and histograms) and inferential statistics, including ANOVA, Kruskal-Wallis tests, and proportion tests as appropriate. Temporal trends over the three-year study period will be analyzed. A retrospective application of the methodology will be performed to evaluate potential improvement signals under continuous monitoring conditions.

    Time frame: December 2026 - March 2027

  5. Number of improvement signals per quality-of-care indicator under simulated continuous monitoring

    A retrospective application of the continuous monitoring methodology will be performed to evaluate the number of improvement signals that would have been detected had the monitoring system been continuously active across participating emergency departments during the study period.

    Time frame: December 2026 - March 2027

07

Study locations

1 site
  • Ospedale Civile SS.Antonio e Biagio
    Alessandria, Italy
    • Riccardo Boverio · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Jul 2027; primary completion for Jan 2028, 6 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 9, 2026: start Jul 2026 → Jul 2027, primary completion Jan 2027 → Jan 2028 and completion Jul 2027 → Jul 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 15, 2026
First posted
May 26, 2026
StartEst.
Jul 1, 2027was Jul 2026
Primary completionEst.
Jan 1, 2028was Jan 2027
CompletionEst.
Jul 1, 2028was Jul 2027
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jul 1, 2026→Jul 1, 2027
Oct 9, 2026
Primary completion
Jan 1, 2027→Jan 1, 2028
Oct 9, 2026
Study completion
Jul 1, 2027→Jul 1, 2028
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Start date Jul 1, 2026→Jul 1, 2027
    Primary completion Jan 1, 2027→Jan 1, 2028
    Study completion Jul 1, 2027→Jul 1, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07606209
Responsible party
Sponsor
First posted
May 26, 2026
Start date
Jul 1, 2027 (estimated)
Primary completion
Jan 1, 2028 (estimated)
Completion
Jul 1, 2028 (estimated)
Last update
Oct 9, 2026

Study contacts

Giovanni Nattino
Contact
giovanni.nattino@marionegri.it
+39 0354535351

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion